A detailed history of Northern Trust Corp transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 325,764 shares of SGHT stock, worth $1.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
325,764
Previous 205,087 58.84%
Holding current value
$1.3 Million
Previous $1.37 Million 50.11%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.49 - $8.31 $662,516 - $1 Million
120,677 Added 58.84%
325,764 $2.05 Million
Q2 2024

Aug 14, 2024

BUY
$5.13 - $7.15 $18,816 - $26,226
3,668 Added 1.82%
205,087 $1.37 Million
Q1 2024

May 14, 2024

BUY
$4.02 - $5.89 $12,381 - $18,141
3,080 Added 1.55%
201,419 $1.06 Million
Q4 2023

Feb 13, 2024

SELL
$1.29 - $5.86 $24,430 - $110,976
-18,938 Reduced 8.72%
198,339 $1.02 Million
Q3 2023

Nov 13, 2023

BUY
$2.88 - $8.8 $30,709 - $93,834
10,663 Added 5.16%
217,277 $732,000
Q2 2023

Aug 11, 2023

SELL
$7.46 - $10.67 $489,211 - $699,717
-65,578 Reduced 24.09%
206,614 $1.71 Million
Q1 2023

May 15, 2023

BUY
$8.44 - $13.35 $102,140 - $161,561
12,102 Added 4.65%
272,192 $2.38 Million
Q4 2022

Feb 13, 2023

BUY
$5.58 - $13.94 $27,146 - $67,818
4,865 Added 1.91%
260,090 $3.18 Million
Q3 2022

Nov 14, 2022

BUY
$6.1 - $11.41 $579,859 - $1.08 Million
95,059 Added 59.35%
255,225 $1.62 Million
Q2 2022

Aug 12, 2022

SELL
$6.61 - $11.99 $102,673 - $186,240
-15,533 Reduced 8.84%
160,166 $1.44 Million
Q1 2022

May 13, 2022

BUY
$11.56 - $17.9 $823,245 - $1.27 Million
71,215 Added 68.16%
175,699 $2.03 Million
Q4 2021

Feb 08, 2022

BUY
$17.36 - $27.36 $82,130 - $129,440
4,731 Added 4.74%
104,484 $1.84 Million
Q3 2021

Nov 15, 2021

BUY
$22.34 - $39.1 $2.23 Million - $3.9 Million
99,753 New
99,753 $2.26 Million

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $190M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.